Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03ABAntidotes
- Chemical substanceV03AB14Protamine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 4 registrations
- Protamine Sulfate Injection, USP10 MG / ML · Solution · Fresenius Kabi Canada LTD
- Protamine Sulfate Injection USP10 MG / ML · Solution · Sandoz Canada Incorporated
- Protamine Sulfate Inj 10MG/ML USP10 MG / ML · Liquid · Lyphomed, Division of Fujisawa Canada INC.
- Protamine Sulfate Injection USP10 MG / ML · Liquid · Omega Laboratories Limited
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- V03AB14
- ATC group
- Various
- Registers
- 8
- Historical lists
- 1
- Registrations
- 19
- With their own page
- 13
- Companies
- 16
All medicines with Protamine
Human medicines from every register that match Protamine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
80 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Protamine Sulfate | United States | 250MG/25ML, 250MG/25ML, 50MG/5ML | solution | Marketed | Hikma |
| Protamine Sulfate | United States | 10MG/ML, 50MG/VIAL | Injectable | Not marketed | Quad Pharms |
| Protamine Sulfate | United States | 250MG/VIAL, 50MG/VIAL | powder | Not marketed | Pharmacia and Upjohn |
| Protamine Sulfate Injection, USP | Canada | 10 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| Protamine Sulfate Injection USP | Canada | 10 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| Protaminehydrochloride MPH 1000 IE/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare B.V. | |
| Protaminehydrochloride MPH 5000 IE/ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare B.V. | |
| Protamine sulfaat LEO Pharma 1400 anti-heparine IE/ml oplossing voor injectie en infusie | Netherlands | Oplossing voor injectie of infusie | Authorised | Leo Pharma A/S | |
| Protamina | Brazil | Authorised | Cellera Farmaceutica S.A. | ||
| Protamin sulfat Galenika | Serbia | 50mg/5mL | rastvor za injekciju | Authorised | Galenika Ad Beograd |
| Protamina Sulfato Leo Pharma 1.400 Ui Anti-Heparina (10MG)/ML Solucion Inyectable y Para Perfusion | Spain | 10 mg/ml | solución inyectable y para perfusión | Marketed | Leo Pharma A/S |
| Prosulf Injection 1% | Singapore | 1% | injection | Authorised | Medipharm Pte LTD |
| Humalog Mix 50/50Combination | United States | 50 UNITS/ML; 50 UNITS/ML | injectable | Marketed | Lilly |
| Humalog Mix 50/50 KwikpenCombination | United States | 50 UNITS/ML; 50 UNITS/ML | injectable | Marketed | Lilly |
| Novolog Mix 70/30Combination | United States | 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML | injectable | Marketed | Novo Nordisk INC |
| Novolog Mix 70/30 FlexpenCombination | United States | 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML | injectable | Marketed | Novo Nordisk INC |
| Any | New Zealand | Inj 10 mg per ml, 5 ml ampoule | Funded | ||
| Humalog Mix 75/25Combination | United States | 75 UNITS/ML; 25 UNITS/ML | injectable | Marketed | Lilly |
| Humalog Mix 75/25 KwikpenCombination | United States | 75 UNITS/ML; 25 UNITS/ML | injectable | Marketed | Lilly |
| Humalog Mix 50/50 PenCombination | United States | 50 UNITS/ML; 50 UNITS/ML | injectable | Not marketed | Lilly |
| Novolog Mix 70/30 PenfillCombination | United States | 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML | injectable | Not marketed | Novo Nordisk INC |
| Humalog Mix 75/25 PenCombination | United States | 75 UNITS/ML; 25 UNITS/ML | injectable | Not marketed | Lilly |
| Prosulf Sulphate Inj 1% | Saudi Arabia | Authorised | CP Pharmaceutical Limited | ||
| Novolog Mix 50/50Combination | United States | 50 UNITS/ML; 50 UNITS/ML | injectable | Not marketed | Novo Nordisk INC |
| Pramine | United States | 10MG, 25MG, 50MG | tablet | Not marketed | Alra |